×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INO – inovio pharmaceuticals, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
07:32 am
ino
Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035, Featuring Profiles of Halozyme, HNS, INOVIO Pharmaceuticals and Medical International Technology and PharmaJet [Yahoo! Finance]
High
Report
Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035, Featuring Profiles of Halozyme, HNS, INOVIO Pharmaceuticals and Medical International Technology and PharmaJet [Yahoo! Finance]
12/13
07:00 am
ino
INOVIO Announces Pricing of $30 Million Public Offering
High
Report
INOVIO Announces Pricing of $30 Million Public Offering
12/12
04:01 pm
ino
INOVIO Announces Proposed Public Offering
High
Report
INOVIO Announces Proposed Public Offering
12/3
01:50 pm
ino
Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer [Yahoo! Finance]
Low
Report
Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer [Yahoo! Finance]
12/3
08:13 am
ino
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial [Yahoo! Finance]
Medium
Report
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial [Yahoo! Finance]
12/3
08:00 am
ino
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
Medium
Report
New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
11/29
04:02 pm
ino
INOVIO Reports Inducement Grant Under Inducement Plan
Low
Report
INOVIO Reports Inducement Grant Under Inducement Plan
11/18
01:06 pm
ino
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Low
Report
Human Papillomavirus Market is Projected to Boost at a Moderate Growth Rate During the Study Period (2020–2034) | DelveInsight [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2024
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-11.0%
inovio pharmaceuticals, inc.
8/8/2024
04:05 pm
ino
inovio pharmaceuticals, inc.
MISS
Report
-6.5%
inovio pharmaceuticals, inc.
5/13/2024
04:05 pm
ino
inovio pharmaceuticals, inc.
MISS
Report
-2.2%
inovio pharmaceuticals, inc.
3/6/2024
04:05 pm
ino
inovio pharmaceuticals, inc.
BEAT
Report
-11.9%
inovio pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/23
08:09 pm
ino
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Stonepine Capital Management, LLC
Low
Report
Form SCHEDULE 13G INOVIO PHARMACEUTICALS, Filed by: Stonepine Capital Management, LLC
12/18
07:02 pm
ino
Form 4 INOVIO PHARMACEUTICALS, For: Dec 18 Filed by: Sumner Michael John
Medium
Report
Form 4 INOVIO PHARMACEUTICALS, For: Dec 18 Filed by: Sumner Michael John
12/16
08:26 am
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Dec 12
Medium
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Dec 12
12/13
04:04 pm
ino
Form 424B5 INOVIO PHARMACEUTICALS,
Medium
Report
Form 424B5 INOVIO PHARMACEUTICALS,
12/12
04:58 pm
ino
Form 424B5 INOVIO PHARMACEUTICALS,
High
Report
Form 424B5 INOVIO PHARMACEUTICALS,
11/14
04:10 pm
ino
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 14
High
Report
Form 8-K INOVIO PHARMACEUTICALS, For: Nov 14
11/14
04:02 pm
ino
Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30
High
Report
Form 10-Q INOVIO PHARMACEUTICALS, For: Sep 30
11/8
02:22 pm
ino
Form SC 13G INOVIO PHARMACEUTICALS, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G INOVIO PHARMACEUTICALS, Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/3
Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800
66.7%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
3/6 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 46.3%
3/10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inovio Pharmaceuticals, Inc. – INO 43.8%
12/19 Inovio Pharmaceuticals Inc (NASDAQ: INO) is now covered by analysts at Roth Capital. They set a "buy" rating and a $13.00 price target on the stock. 20.7%
3/5 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock. 20.4%
1/25 Inovio Pharmaceuticals Inc (NASDAQ: INO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock. 19.6%
3/26 Form 4 INOVIO PHARMACEUTICALS, For: Mar 25 Filed by: Shea Jacqueline Elizabeth 17.7%
4/24 Inovio Pharmaceuticals Inc (NASDAQ: INO) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. 16.9%
3/16 HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Inovio Pharmaceuticals (INO) Investors with Significant Losses to Contact its Attorneys: Securities Fraud Class Action Filed 16.3%
4/3 Form 8-K INOVIO PHARMACEUTICALS, For: Apr 03 14.8%
TOP News Decliners
3/9
Form 8-K INOVIO PHARMACEUTICALS, For: Mar 03
-47.6%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
3/9 Form 4 INOVIO PHARMACEUTICALS, For: Mar 05 Filed by: Humeau Laurent -43.8%
3/12 Form 4 INOVIO PHARMACEUTICALS, For: Mar 10 Filed by: KIES PETER -24.2%
1/27 Dow Falls 350 Points as Coronavirus Fears Grow [The Motley Fool] -20.3%
6/10 Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device -16.7%
3/23 The U.S. Needs China’s Masks, as Acrimony Grows [The New York Times] -15.7%
1/29 Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial -15.3%
3/13 ROSEN, A GLOBALLY RECOGNIZED FIRM, Announces Filing of Securities Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. – INO -14.6%
4/27 INOVIO to Report First Quarter 2020 Financial Results on May 11, 2020 -14.3%
1/31 Form S-8 INOVIO PHARMACEUTICALS, -13.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: